Cambium Bio Ltd Asset Resilience Ratio

Latest as of June 2023: 0.00%

Cambium Bio Ltd asset resilience ratio. Cambium Bio Ltd (CMB) has an Asset Resilience Ratio of 0.00% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See CMB days of operational coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

AU$0.00

≈ $0.00 USD Cash + Short-term Investments

Total Assets

AU$2.48 Million

≈ $1.76 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Cambium Bio Ltd (2013–2023)

Asset resilience ratio of Cambium Bio Ltd from 2013 to 2023. This chart shows how Cambium Bio Ltd's Asset Resilience Ratio has changed over time. Read CMB liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Cambium Bio Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see CMB total asset value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$0.00	0.00%

Asset Resilience Insights

Limited Liquidity: Cambium Bio Ltd maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Cambium Bio Ltd Industry Peers by Asset Resilience Ratio

Compare Cambium Bio Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Samsung Biologics Co Ltd KO:207940	Biotechnology	15.21%
Abivax SA PA:ABVX	Biotechnology	2.58%
Tubize-Fin BR:TUB	Biotechnology	2.50%
BB Biotech AG SW:BION	Biotechnology	92.97%
Sinocelltech Group Ltd SHG:688520	Biotechnology	5.27%
Inner Mongolia Furui Med Sci SHE:300049	Biotechnology	1.75%
Mineralys Therapeutics, Inc. Common Stock NASDAQ:MLYS	Biotechnology	78.33%
GH Research PLC NASDAQ:GHRS	Biotechnology	4.73%

Cambium Bio Ltd Asset Resilience Ratio by Year (2013–2023)

Cambium Bio Ltd asset resilience ratio by year from 2013 to 2023. The table below shows the annual Asset Resilience Ratio data for Cambium Bio Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-06-30	0.00%	AU$0.00 ≈ $0.00	AU$2.48 Million ≈ $1.76 Million	--
2022-06-30	2.71%	AU$69.27K ≈ $49.02K	AU$2.55 Million ≈ $1.81 Million	-3.99pp
2021-06-30	6.70%	AU$570.23K ≈ $403.47K	AU$8.51 Million ≈ $6.02 Million	-5.21pp
2020-06-30	11.91%	AU$570.23K ≈ $403.47K	AU$4.79 Million ≈ $3.39 Million	-11.55pp
2019-06-30	23.45%	AU$596.16K ≈ $421.82K	AU$2.54 Million ≈ $1.80 Million	--
2017-06-30	0.00%	AU$0.00 ≈ $0.00	AU$9.16 Million ≈ $6.48 Million	--
2016-06-30	0.00%	AU$0.00 ≈ $0.00	AU$5.93 Million ≈ $4.20 Million	--
2014-06-30	1.25%	AU$127.75K ≈ $90.39K	AU$10.26 Million ≈ $7.26 Million	-1.81pp
2013-06-30	3.06%	AU$122.93K ≈ $86.98K	AU$4.02 Million ≈ $2.85 Million	--

pp = percentage points

About Cambium Bio Ltd

AU:CMB Australia Biotechnology

Market Cap

$6.96 Million

AU$9.84 Million AUD

Market Cap Rank

#27780 Global

#1378 in Australia

Share Price

AU$0.36

Change (1 day)

-10.00%

52-Week Range

AU$0.35 - AU$0.60

All Time High

AU$22.97